<--- Back to Details
First PageDocument Content
Food and Drug Administration / Clinical pharmacology / Therapeutics / United States Public Health Service / Prescription Drug User Fee Act / Myelodysplastic syndrome / Biosimilar / Ciprofloxacin / Infliximab / Medicine / Pharmacology / Health
Date: 2014-08-08 11:47:10
Food and Drug Administration
Clinical pharmacology
Therapeutics
United States Public Health Service
Prescription Drug User Fee Act
Myelodysplastic syndrome
Biosimilar
Ciprofloxacin
Infliximab
Medicine
Pharmacology
Health

New 2010 Pipeline Database

Document is deleted from original location.
Use the Download Button below to download from the Web Archive.

Download Document from Web Archive

File Size: 214,97 KB